Environment
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
StateNew JerseyReported
A 2281: Requires Medicaid coverage for fertility preservation services in cases of iatrogenic infertility caused by medically necessary treatments.
Donlon, Margie, M.D.
A 2281 status: Reported — Reported and Referred to Assembly Appropriations Committee (updated Sep 17, 2026).
Source
LegiScan
Confidence
High
Analysis basis
LegiScan full bill text
01
What this bill does
Official summary alongside an AI-generated read on where it stands and why.
Overall Score
75OUT OF 100
Score:75/100 civic fit
Risk:Low Risk
Impact:Moderate Impact 40/100
Constitutionality95%
Bipartisan75%
Public opinion85%
Bill summary
What changes
The bill mandates that New Jersey's Medicaid program cover fertility preservation services (like egg or sperm freezing) for patients undergoing medical treatments that cause iatrogenic infertility, such as chemotherapy or radiation.
Who is affected
Medicaid beneficiaries who are facing medical treatments, such as cancer treatment, that are likely to cause permanent infertility.
Requirements and enforcement
The coverage applies to 'standard fertility preservation services' as defined by professional medical guidelines. It is limited to one cycle unless the procedure is unsuccessful.
Costs and funding
Requires state Medicaid funding; however, the bill explicitly conditions the implementation on securing federal financial participation.
When it takes effect
Takes effect immediately upon passage, but implementation awaits required federal state plan amendments or waivers.
Potential benefits
Enables cancer patients and others requiring intensive treatments to preserve their ability to have biological children in the future, improving long-term psychosocial outcomes.
Risks and tradeoffs
Potential for bureaucratic delays in obtaining federal approval and the risk that geographic availability of fertility clinics may limit the program's real-world utility.
What is still unknown
The final fiscal burden on the state and the speed at which the federal government will approve the necessary state plan amendments.
02
Impact analysis
✦ AI analysisModeled effects across six domains, estimated from bill text and comparable legislation.
Economy
Positive outlook
60%
Benefits
- Provides financial assistance to low-income patients for expensive procedures
- Reduces out-of-pocket medical costs for vulnerable populations
- Supports revenue stability for medical providers offering reproductive services
Risks
- Increases aggregate state-level Medicaid expenditures
- Requires administrative updates to billing systems and provider manuals
- Creates fiscal dependence on continued federal financial participation
Society
Positive outlook
80%
Benefits
- Expands reproductive choice for patients facing life-altering medical treatments
- Reduces health disparities between high- and low-income cancer survivors
- Supports long-term life planning for younger medical patients
Risks
- Risk of patient confusion regarding specific clinical eligibility criteria
- Availability of specialized reproductive clinics varies geographically within the state
- Long-term reliance on legislative funding for continued benefit coverage
Technology Industry
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
Civic Accountability
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
Public Health & Safety
Positive outlook
85%
Benefits
- Ensures access to fertility preservation for those needing essential medical treatments
- Aligns state coverage with established professional medical guidelines
- Promotes improved long-term quality of life for cancer survivors
Risks
- Inherent medical risks associated with fertility preservation procedures
- Variable success rates of preservation cycles despite clinical coverage
- Potential for delayed cancer treatment if authorization processes are inefficient
03
How trustworthy & consequential it is
Sourcing already shown above, this is what the analysis found worth flagging.
Source
LegiScan
Official bill text or data from LegiScan.
Confidence
High
Information is complete and verified.
Analysis basis
LegiScan full bill text
Source used for this bill's analysis.
Source note
Successful implementation depends entirely on securing necessary state plan amendments and federal waivers
Analysis scope
Fiscal impact is contingent on future federal financial participation approvals
04
Where it stands
Official record- IntroducedComplete
- CommitteeCurrent
- Chamber votesUpcoming
- Final agreementUpcoming
- GovernorUpcoming
- EnactedUpcoming
05
How it affects your district
✦ Personalized
Set your location
Add your district to see how this bill may affect your community and who to contact.
Your Representatives
Your representatives appear here once you add your location.
06
Take action
Contact your representatives
Let them know how you feel about this bill.
Share your view
Join the discussion and see what others are saying.
Track this bill
Stay updated on progress and changes.